ANA as an entry criterion for the classification of SLE

被引：50

作者：

Pisetsky, David S. ^{[1
,2
,3
]}

Bossuyt, Xavier ^{[4
]}

Meroni, Pier Luigi ^{[5
]}

机构：

[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA

[3] Vet Adm Med Ctr, Med Res Serv, Durham, NC USA

[4] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium

[5] IRCCS Inst Auxol Italiano, Immunorheumatol Res Lab, Milan, Italy

来源：

AUTOIMMUNITY REVIEWS | 2019年 / 18卷 / 12期

关键词：

Systemic lupus erythematosus; Antinuclear antibody; Classification criteria; HEp2 immunofluorescence assay; Solid phase assays; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ELIA CTD SCREEN; ANTINUCLEAR ANTIBODIES; INDIRECT IMMUNOFLUORESCENCE; CLINICAL UTILITY; AUTOANTIBODIES; IMMUNOASSAY; DISEASE; FLUCTUATION; PREVALENCE;

D O I：

10.1016/j.autrev.2019.102400

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with highly variable clinical and immunological manifestations. In the classification of patients with this condition, the presence of an antinuclear antibody (ANA) is an important element, with new criteria from the American College of Etheumatology and European League against Rheumatism positioning ANA positivity by an immunofluorescence assay on HEp2-cells (HEp2-IFA) or by an equivalent solid phase assay as the entry criterion. This positioning is based on assumptions about the frequency of ANA positivity in SLE as well as the reliability of the assays. Studies indicate that these assumptions are still a matter of uncertainty since both types of assay show considerable variability and patients with SLE may display negative results in ANA testing. These findings suggest caution in positioning ANA positivity as an entry criterion for classification and point to the value of alternative serological approaches for ANA determinations.

引用

收藏

页数：5

相关论文

共 50 条

[21] SLE classification criteria: Is "The causality principle" integrated and operative - and do the molecular and genetical network, on which criteria depend on, support the definition of SLE as "a one disease entity" - A theoretical discussion [J].

Rekvig, Ole Petter .

AUTOIMMUNITY REVIEWS, 2023, 22 (12)

[22] Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature [J].

Theisen, Alexandra ;

Bose, Paroma ;

Knight, Christina ;

Oliver, Melissa .

PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)

[23] European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance [J].

Aringer, Martin ;

Brinks, Ralph ;

Doerner, Thomas ;

Daikh, David ;

Mosca, Marta ;

Ramsey-Goldman, Rosalind ;

Smolen, Josef S. ;

Wofsy, David ;

Boumpas, Dimitrios T. ;

Kamen, Diane L. ;

Jayne, David ;

Cervera, R. ;

Costedoat-Chalumeau, Nathalie ;

Diamond, Betty ;

Gladman, Dafna D. ;

Hahn, Bevra ;

Hiepe, Falk ;

Jacobsen, Soren ;

Khanna, Dinesh ;

Lerstrom, Kirsten ;

Massarotti, Elena ;

McCune, Joseph ;

Ruiz-Irastorza, Guillermo ;

Sanchez-Guerrero, Jorge ;

Schneider, Matthias ;

Urowitz, Murray ;

Bertsias, George ;

Hoyer, Bimba F. ;

Leuchten, Nicolai ;

Schmajuk, Gabriela ;

Tani, Chiara ;

Tedeschi, Sara K. ;

Touma, Zahi ;

Anic, Branimir ;

Assan, Florence ;

Chan, Tak Mao ;

Clarke, Ann Elaine ;

Crow, Mary K. ;

Czirjak, Laszlo ;

Doria, Andrea ;

Graninger, Winfried ;

Halda-Kiss, Bernadett ;

Hasni, Sarfaraz ;

Izmirly, Peter M. ;

Jung, Michelle ;

Kumanovics, Gabor ;

Mariette, Xavier ;

Padjen, Ivan ;

Pego-Reigosa, Jose M. ;

Romero-Diaz, Juanita .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (06) :775-781

[24] New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion [J].

Sacre, Karim ;

Delaval, Laure ;

Dossier, Antoine ;

Alexandra, Jean-Francois ;

Berleur, Marie ;

Chauveheid, Marie-Paule ;

Ducrocq, Gregory ;

Goulenok, Tiphaine ;

van Gysel, Damien ;

Rouzaud, Diane ;

Papo, Thomas .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (12)

[25] Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks [J].

Rekvig, O. P. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 179 (01) :5-10

[26] Response to: 'Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi et al [J].

Aringer, Martin ;

Costenbader, Karen H. ;

Doerner, Thomas ;

Johnson, Sindhu R. .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08)

[27] Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria? [J].

Signorelli, Flavio ;

Balbi, Gustavo Guimaraes Moreira ;

Bonfa, Eloisa ;

Borba, Eduardo F. ;

Andrade, Danieli Castro de Oliveira .

LUPUS, 2021, 30 (11) :1732-1738

[28] Classification of ANA HEp-2 slide images using morphological features of stained patterns [J].

Ponomarev, Gennady V. ;

Kazanov, Marat D. .

PATTERN RECOGNITION LETTERS, 2016, 82 :79-84

[29] Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease [J].

Magallares, Berta ;

Lobo-Prat, David ;

Castellvi, Ivan ;

Moya, Patricia ;

Gich, Ignasi ;

Martinez-Martinez, Laura ;

Park, Hye ;

Millan, Ana Milena ;

Laiz, Ana ;

Diaz-Torne, Cesar ;

Fernandez, Susana ;

Corominas, Hector .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)

[30] Response to: 'New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS' by Assan et al [J].

Aringer, Martin ;

Costenbader, Karen ;

Dorner, Thomas ;

Johnson, Sindhu R. .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08)

← 1 2 3 4 5 →